Tolerance to ethanol sedation and withdrawal hyper-excitability is mediated via neuropeptide Y Y1 and Y5 receptors

Life Sciences

Volumn 85, Issue 21-22, 2009, Pages 765-772

  Bhisikar, Snehal M ^a   Kokare, Dadasaheb M ^a   Nakhate, Kartik T ^a   Chopde, Chandrabhan T ^a   Subhedar, Nishikant K ^b  

^a RTM NAGPUR UNIVERSITY   (India)

^b INDIAN INSTITUTE OF SCIENCE EDUCATION AND RESEARCH   (India)

Author keywords

Blood ethanol levels; Ethanol tolerance; Ethanol withdrawal; Neuropeptide Y Y1 and Y5 receptors; Righting reflex; Sedation

Indexed keywords

ALCOHOL; NEUROPEPTIDE Y [31 LEUCINE 34 PROLINE]; NEUROPEPTIDE Y RECEPTOR AGONIST; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y5 RECEPTOR;

ADULT ANIMAL; ALCOHOL TOLERANCE; ALCOHOL WITHDRAWAL; ANIMAL EXPERIMENT; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; MALE; MOUSE; NONHUMAN; PROTEIN LOCALIZATION; RECEPTOR INTRINSIC ACTIVITY; RIGHTING REFLEX; SEDATION; TISSUE DISTRIBUTION;

ALCOHOL WITHDRAWAL DELIRIUM; ANIMALS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; DRUG TOLERANCE; ETHANOL; MALE; MICE; NEUROPEPTIDE Y; POSTURAL BALANCE; RECEPTORS, NEUROPEPTIDE Y; REFLEX;

MUS;

EID: 70449106025     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2009.10.007     Document Type: Article

References (98)

1. Allan A.M., Spuhler K.P., and Harris R.A. Gamma-aminobutyric acid-activated chloride channels: relationship to genetic differences in ethanol sensitivity. The Journal of Pharmacology and Experimental Therapeutics 244 3 (1988) 866-870
2. Bison S., and Crews F. Alcohol withdrawal increases neuropeptide Y immunoreactivity in rat brain. Alcoholism: Clinical and Experimental Research 27 7 (2003) 1173-1183
3. Brailowsky S., and García O. Ethanol, GABA and epilepsy. Archives of Medical Research 30 1 (1999) 3-9
4. Britton K.T., Southerland S., Van Uden E., Kirby D., Rivier J., and Koob G. Anxiolytic activity of NPY receptor agonists in the conflict test. Psychopharmacology (Berl) 132 1 (1997) 6-13
5. Carvajal F., López-Grancha M., Navarro M., Sánchez-Amate Mdel C., and Cubero I. Long-lasting reductions of ethanol drinking, enhanced ethanol-induced sedation, and decreased c-fos expression in the Edinger-Westphal nucleus in Wistar rats exposed to the organophosphate chlorpyrifos. Toxicological Sciences 96 2 (2007) 310-320
6. Cippitelli A., Bilbao A., Hansson A.C., del Arco I., Sommer W., Heilig M., Massi M., Bermúdez-Silva F.J., Navarro M., Ciccocioppo R., and de Fonseca F.R. Cannabinoid CB1 receptor antagonism reduces conditioned reinstatement of ethanol-seeking behavior in rats. The European Journal of Neuroscience 21 8 (2005) 2243-2251
7. Clark J.T., Keaton A.K., Sahu A., Kalra S.P., Mahajan S.C., and Gudger J.N. Neuropeptide Y (NPY) levels in alcoholic and food restricted male rats: implications for site selective function. Regulatory Peptides 75-76 (1998) 335-345
8. Dalvi A., and Rodgers R.J. GABAergic influences on plus-maze behaviour in mice. Psychopharmacology (Berl) 128 4 (1996) 380-397
9. Dandekar M.P., Singru P.S., Kokare D.M., Lechan R.M., Thim L., Clausen J.T., and Subhedar N.K. Importance of cocaine- and amphetamine-regulated transcript peptide in the central nucleus of amygdala in anxiogenic responses induced by ethanol withdrawal. Neuropsychopharmacology 33 5 (2008) 1127-1136
10. Devaud L.L., Fritschy J.M., Sieghart W., and Morrow A.L. Bidirectional alterations of GABA(A) receptor subunit peptide levels in rat cortex during chronic ethanol consumption and withdrawal. Journal of Neurochemistry 69 1 (1997) 126-130
11. Diana M., Gessa G.L., and Rossetti Z.L. Lack of tolerance to ethanol-induced stimulation of mesolimbic dopamine system. Alcohol and Alcoholism 27 4 (1992) 329-333
12. Dumont Y., Martel J.C., Fournier A., St-Pierre S., and Quirion R. Neuropeptide Y and neuropeptide Y receptor subtypes in brain and peripheral tissues. Progress in Neurobiology 38 2 (1992) 125-167
13. Ehlers C.L., Li T.K., Lumeng L., Hwang B.H., Somes C., Jimenez P., and Mathé A.A. Neuropeptide Y levels in ethanol-naive alcohol-preferring and non-preferring rats and in Wister rats after ethanol exposure. Alcoholism: Clinical and Experimental Research 22 8 (1998) 1778-1782
14. Ehlers C.L., Somes C., Seifritz E., and Rivier J.E. CRF/NPY interactions: a potential role in sleep dysregulation in depression and anxiety. Depression and Anxiety 6 1 (1997) 1-9
15. Erwin V.G., Radcliffe R., and Deitrich R.A. Neurotensin levels in specific brain regions and hypnotic sensitivity to ethanol and pentobarbital as a function of time after haloperidol administration in selectively bred rat lines. The Journal of Pharmacology and Experimental Therapeutics 299 2 (2001) 698-704
16. Evenden J.L., and Ryan C.N. The pharmacology of impulsive behaviour in rats VI: the effects of ethanol and selective serotonergic drugs on response choice with varying delays of reinforcement. Psychopharmacology (Berl) 146 4 (1999) 413-421
17. Fee J.R., Sparta D.R., Knapp D.J., Breese G.R., Picker M.J., and Thiele T.E. Predictors of high ethanol consumption in RIIbeta knock-out mice: assessment of anxiety and ethanol-induced sedation. Alcoholism: Clinical and Experimental Research 28 10 (2004) 1459-1468
18. Feng H.J., Yang L., and Faingold C.L. Role of the amygdala in ethanol withdrawal seizures. Brain Research 1141 (2007) 65-73
19. Franklin K.B.J., and Paxinos G. The Mouse Brain in Stereotaxic Coordinates (1997), Academic Press, CA
20. Friedman H.J. Assessment of physical dependence on and withdrawal from ethanol in animals. In: Righter H., and Crabbe J.C. (Eds). Alcohol Tolerance and Dependence (1980), North Holland Biomedical Press, Amsterdam 93-121
21. Fuxe K., Agnati L.F., Härfstrand A., Zini I., Tatemoto K., Pich E.M., Hökfelt T., Mutt V., and Terenius L. Central administration of neuropeptide Y induces hypotension bradypnea and EEG synchronization in the rat. Acta Physiologica Scandinavica 118 2 (1983) 189-192
22. Gatch M.B., and Selvig M. Theophylline blocks ethanol withdrawal-induced hyperalgesia. Alcohol and Alcoholism 37 4 (2002) 313-317
23. Gill K., and Deitrich R.A. Acute tolerance to the ataxic effects of ethanol in short-sleep (SS) and long-sleep (LS) mice. Psychopharmacology (Berl) 136 1 (1998) 91-98
24. Gilpin N.W., Stewart R.B., Elder R.L., Kho Y., Murphy J.M., Li T.K., and Badia-Elder N.E. Sedative and motor impairing effects of neuropeptide Y and ethanol in selectively bred P and NP rats. Pharmacology, Biochemistry and Behavior 78 1 (2004) 65-73
25. Gilpin N.W., Stewart R.B., Murphy J.M., and Badia-Elder N.E. Neuropeptide Y in the paraventricular nucleus of the hypothalamus increases ethanol intake in high- and low-alcohol-drinking rats. Alcoholism: Clinical and Experimental Research 28 10 (2004) 1492-1498
26. Givens B.S., and Breese G.R. Site-specific enhancement of gamma-aminobutyric acid-mediated inhibition of neural activity by ethanol in the rat medial septal area. Journal of Pharmacology and Experimental Therapeutics 254 2 (1990) 528-538
27. Gray T.S., and Morley J.E. Neuropeptide Y: anatomical distribution and possible function in mammalian nervous system. Life Sciences 38 5 (1986) 389-401
28. Haughey H.M., Kaiser A.L., Johnson T.E., Bennett B., Sikela J.M., and Zahniser N.R. Norepinephrine transporter: a candidate gene for initial ethanol sensitivity in inbred long-sleep and short-sleep mice. Alcoholism: Clinical and Experimental Research 29 10 (2005) 1759-1768
29. Haynes A.C., Arch J.R., Wilson S., McClue S., and Buckingham R.E. Characterisation of the neuropeptide Y receptor that mediates feeding in the rat: a role for the Y5 receptor?. Regulatory Peptides 75-76 (1998) 355-361
30. Heilig M., Koob G.F., Ekman R., and Britton K.T. Corticotropin-releasing factor and neuropeptide Y: role in emotional integration. Trends in Neurosciences 17 2 (1994) 80-85
31. Held K., Antonijevic I., Murck H., Kuenzel H., and Steiger A. Neuropeptide Y (NPY) shortens sleep latency but does not suppress ACTH and cortisol in depressed patients and normal controls. Psychoneuroendocrinology 31 1 (2006) 100-107
32. Hirani K., Sharma A.N., Jain N.S., Ugale R.R., and Chopde C.T. Evaluation of GABAergic neuroactive steroid 3alpha-hydroxy-5alpha-pregnane-20-one as a neurobiological substrate for the anti-anxiety effect of ethanol in rats. Psychopharmacology (Berl) 180 2 (2005) 267-278
33. June H.L., Cason C.R., Cheatham G., Lui R., Gan T., and Cook J.M. GABAA-benzodiazepine receptors in the striatum are involved in the sedation produced by a moderate, but not an intoxicating ethanol dose in outbred Wistar rats. Brain Research 794 1 (1998) 103-118
34. Kalange A.S., Kokare D.M., Singru P.S., Upadhya M.A., Chopde C.T., and Subhedar N.K. Central administration of selective melanocortin-4 receptor antagonist HS014 prevents morphine tolerance and withdrawal hyperalgesia. Brain Research 1181 (2007) 10-20
35. Kamdi S.P., Nakhate K.T., Dandekar M.P., Kokare D.M., and Subhedar N.K. Participation of corticotropin-releasing factor type 2 receptors in the acute, chronic and withdrawal actions of nicotine associated with feeding behavior in rats. Appetite (2009) 10.1016/j.appet.2009.07.017
36. Kask A., Rago L., and Harro J. Alpha-helical CRF(9-41) prevents anxiogenic-like effect of NPY Y1 receptor antagonist BIBP3226 in rats. Neuroreport 8 16 (1997) 3645-3647
37. Kelley S.P., Nannini M.A., Bratt A.M., and Hodge C.W. Neuropeptide Y in paraventricular nucleus increases ethanol self administration. Peptides 22 3 (2001) 515-522
38. Khanna J.M., Morato G.S., Chau A., Shah G., and Kalant H. Effect of NMDA antagonists on rapid and chronic tolerance to ethanol: importance of intoxicated practice. Pharmacology, Biochemistry and Behavior 48 3 (1994) 755-763
39. Khisti R.T., VanDoren M.J., O'Buckley T., and Morrow A.L. Neuroactive steroid 3 alpha-hydroxy-5 alpha-pregnan-20-one modulates ethanol-induced loss of righting reflex in rats. Brain Research 980 2 (2003) 255-265
40. Koban M., Le W., and Hoffman G.E. Changes in hypothalamic corticotropin-releasing hormone, neuropeptide Y, and proopiomelanocortin gene expression during chronic rapid eye movement sleep deprivation of rats. Endocrinology 147 1 (2006) 421-431
41. Kokare D.M., Chopde C.T., and Subhedar N.K. Participation of α-melanocyte stimulating hormone in ethanol-induced anxiolysis and withdrawal anxiety in rats. Neuropharmacology 51 3 (2006) 536-545
42. Kokare D.M., Dandekar M.P., Chopde C.T., and Subhedar N. Interaction between neuropeptide Y and alpha-melanocyte stimulating hormone in amygdala regulates anxiety in rats. Brain Research 1043 1-2 (2005) 107-114
43. Kokare D.M., Singru P.S., Dandekar M.P., Chopde C.T., and Subhedar N.K. Involvement of alpha-melanocyte stimulating hormone (α-MSH) in differential ethanol exposure and withdrawal related depression in rat: neuroanatomical-behavioral correlates. Brain Research 1216 (2008) 53-67
44. Koob G.F., and Le Moal M. Drug addiction, dysregulation of reward, and allostasis. Neuropsychopharmacology 24 2 (2001) 97-129
45. Läck A.K., Ariwodola O.J., Chappell A.M., Weiner J.L., and McCool B.A. Ethanol inhibition of kainate receptor-mediated excitatory neurotransmission in the rat basolateral nucleus of the amygdala. Neuropharmacology 55 5 (2008) 661-668
46. Linnoila M., Eckardt M., Durcan M., Lister R., and Martin P. Interactions of serotonin with ethanol: clinical and animal studies. Psychopharmacology Bulletin 23 3 (1987) 452-457
47. Lovinger D.M. Alcohols and neurotransmitter gated ion channels: past, present and future. Naunyn-Schmiedeberg's Archives of Pharmacology 356 3 (1997) 267-282
48. McBride W.J., Murphy J.M., Gatto G.J., Levy A.D., Yoshimoto K., Lumeng L., and Li T.K. CNS mechanisms of alcohol self-administration. Alcohol and Alcoholism 2 (1993) 463-467
49. McGivern R.F., Harris J.M., Yessaian N., Kastin A.J., Coy D.H., Sandman C.A., and Noble E.P. Antagonism of ethanol induced sleep-time by alpha-msh, MSH/ACTH4-10 and naloxone. Substance and Alcohol Actions/Misuse 1 4 (1980) 335-342
50. Mikolajczak P., Okulicz-Kozaryn I., Szczawinska K., Kaminska E., and Kus K. Zolpidem involvement on memory and hypnotic effect of ethanol in chronically ethanol-treated rats. Alcohol and Alcoholism 34 4 (1999) 511-519
51. Naassila M., Ledent C., and Daoust M. Low ethanol sensitivity and increased ethanol consumption in mice lacking adenosine A2A receptors. The Journal of Neuroscience 22 23 (2002) 10487-10493
52. Nakhate K.T., Dandekar M.P., Kokare D.M., and Subhedar N.K. Involvement of neuropeptide Y Y(1) receptors in the acute, chronic and withdrawal effects of nicotine on feeding and body weight in rats. European Journal of Pharmacology 609 1-3 (2009) 78-87
53. Naveilhan P., Canals J.M., Arenas E., and Ernfors P. Distinct roles of the Y1 and Y2 receptors on neuropeptide Y-induced sensitization to sedation. Journal of Neurochemistry 78 6 (2001) 1201-1207
54. Naveilhan P., Canals J.M., Valjakka A., Vartiainen J., Arenas E., and Ernfors P. Neuropeptide Y alters sedation through a hypothalamic Y1-mediated mechanism. The European Journal of Neuroscience 13 12 (2001) 2241-2276
55. Newton P.M., Orr C.J., Wallace M.J., Kim C., Shin H.S., and Messing R.O. Deletion of N-type calcium channels alters ethanol reward and reduces ethanol consumption in mice. The Journal of Neuroscience 24 44 (2004) 9862-9869
56. Okubo T., and Harada S. Polymorphism of the neuropeptide Y gene: an association study with alcohol withdrawal. Alcoholism: Clinical and Experimental Research 25 6 Suppl (2001) 59S-62S
57. Overstreet D.H., Knapp D.J., Angel R.A., Navarro M., and Breese G.R. Reduction in repeated ethanol-withdrawal-induced anxiety-like behavior by site-selective injections of 5-HT1A and 5-HT2C ligands. Psychopharmacology (Berl) 187 1 (2006) 1-12
58. Pandey S.C., Ugale R., Zhang H., Tang L., and Prakash A. Brain chromatin remodeling: a novel mechanism of alcoholism. The Journal of Neuroscience 28 14 (2008) 3729-3737
59. Peris J., Coleman-Hardee M., Burry J., and Pecins-Thompson M. Selective changes in GABAergic transmission in substantia nigra and superior colliculus caused by ethanol and ethanol withdrawal. Alcoholism: Clinical and Experimental Research 16 2 (1992) 311-319
60. Ponomarev I., and Crabbe J.C. A novel method to assess initial sensitivity and acute functional tolerance to hypnotic effects of ethanol. The Journal of Pharmacology and Experimental Therapeutics 302 1 (2002) 257-263
61. Primeaux S.D., Wilson S.P., Bray G.A., York D.A., and Wilson M.A. Overexpression of neuropeptide Y in the central nucleus of the amygdala decreases ethanol self-administration in "anxious" rats. Alcoholism: Clinical and Experimental Research 30 5 (2006) 791-801
62. Rao T.L., Kokare D.M., Sarkar S., Khisti R.T., Chopde C.T., and Subhedar N. GABAergic agents prevent alpha-melanocyte stimulating hormone induced anxiety and anorexia in rats. Pharmacology, Biochemistry and Behavior 76 3-4 (2003) 417-423
63. Rivier C., Imaki T., and Vale W. Prolonged exposure to alcohol: effect on CRF mRNA levels, and CRF- and stress-induced ACTH secretion in the rat. Brain Research 520 1-2 (1990) 1-5
64. Roberto M., Gilpin N.W., O'Dell L.E., Cruz M.T., Morse A.C., Siggins G.R., and Koob G.F. Cellular and behavioral interactions of gabapentin with alcohol dependence. The Journal of Neuroscience 28 37 (2008) 9087-9089
65. Roy A., and Pandey S.C. The decreased cellular expression of neuropeptide Y protein in rat brain structures during ethanol withdrawal after chronic ethanol exposure. Alcoholism: Clinical and Experimental Research 26 6 (2002) 796-803
66. Sajdyk T.J., Fitz S.D., and Shekhar A. The role of neuropeptide Y in the amygdala on corticotropin-releasing factor receptor-mediated behavioral stress responses in the rat. Stress 9 1 (2006) 21-28
67. Sharma A.N., Chopde C.T., Hirani K., Kokare D.M., and Ugale R.R. Chronic progesterone treatment augments while dehydroepiandrosterone sulphate prevents tolerance to ethanol anxiolysis and withdrawal anxiety in rats. European Journal of Pharmacology 567 3 (2007) 211-222
68. Shen E.H., Dorow J.D., Huson M., and Phillips T.J. Correlated responses to selection in FAST and SLOW mice: effects of ethanol on ataxia, temperature, sedation, and withdrawal. Alcoholism: Clinical and Experimental Research 20 4 (1996) 688-696
69. Silveri M.M., and Spear L.P. The effects of NMDA and GABAA pharmacological manipulations on acute and rapid tolerance to ethanol during ontogeny. Alcoholism: Clinical and Experimental Research 28 6 (2004) 884-894
70. Slawecki C.J., Somes C., and Ehlers C.L. Effect of chronic ethanol exposure on neurophysiological responses to corticotrophin-releasing factor and neuropeptide Y. Alcohol and Alcoholism 34 3 (1999) 289-299
71. Sorensen G., Lindberg C., Wortwein G., Bolwig T.G., and Woldbye D.P. Differential roles for neuropeptide Y Y1 and Y5 receptors in anxiety and sedation. Journal of Neuroscience Research 77 5 (2004) 723-729
72. Starowicz K., Obara I., Przewlocki R., and Przewlocka B. Inhibition of morphine tolerance by spinal melanocortin receptor blockade. Pain 117 3 (2005) 401-411
73. Stepanyan T.D., Farook J.M., Kowalski A., Kaplan E., Barron S., and Littleton J.M. Alcohol withdrawal-induced hippocampal neurotoxicity in vitro and seizures in vivo are both reduced by memantine. Alcoholism: Clinical and Experimental Research 32 12 (2008) 2128-2135
74. Thiele T.E., Koh M.T., and Pedrazzini T. Voluntary alcohol consumption is controlled via the neuropeptide Y Y1 receptor. The Journal of Neuroscience 22 3 (2002) RC208
75. Thiele T.E., Marsh D.J., Ste Marie L., Bernstein I.L., and Palmiter R.D. Ethanol consumption and resistance are inversely related to neuropeptide Y levels. Nature 396 6709 (1998) 366-369
76. Thiele T.E., Miura G.I., Marsh D.J., Bernstein I.L., and Palmiter R.D. Neurobiological responses to ethanol in mutant mice lacking neuropeptide Y or the Y5 receptor. Pharmacology, Biochemistry and Behavior 67 4 (2000) 683-691
77. Thiele T.E., Sparta D.R., Fee J.R., Navarro M., and Cubero I. Central neuropeptide Y alters ethanol-induced sedation, but not ethanol intake, in C57BL/6 mice. Alcohol 31 3 (2003) 155-160
78. Thiele T.E., Sparta D.R., Hayes D.M., and Fee J.R. A role for neuropeptide Y in neurobiological responses to ethanol and drugs of abuse. Neuropeptides 38 4 (2004) 235-243
79. Thorsell A., Repunte-Canonigo V., O'Dell L.E., Chen S.A., King A.R., Lekic D., Koob G.F., and Sanna P.P. Viral vector-induced amygdala NPY overexpression reverses increased alcohol intake caused by repeated deprivations in Wistar rats. Brain 130 Pt 5 (2007) 1330-1337
80. Umathe S.N., Bhutada P.S., Raut V.S., Jain N.S., and Mundhada Y.R. The 5-HT3 receptor antagonist, ondansetron, blocks the development and expression of ethanol-induced locomotor sensitization in mice. Behavioural Pharmacology 20 1 (2009) 78-83
81. Uzbay I.T. Serotonergic anti-depressants and ethanol withdrawal syndrome: a review. Alcohol and Alcoholism 43 1 (2008) 15-24
82. Valverius P., Crabbe J.C., Hoffman P.L., and Tabakoff B. NMDA receptors in mice bred to be prone or resistant to ethanol withdrawal seizures. European Journal of Pharmacology 184 1 (1990) 185-189
83. van den Pol A.N., Obrietan K., Chen G., and Belousov A.B. Neuropeptide Y-mediated long-term depression of excitatory activity in suprachiasmatic nucleus neurons. The Journal of Neuroscience 16 18 (1996) 5883-5895
84. Veatch L.M., and Becker H.C. Electrographic and behavioral indices of ethanol withdrawal sensitization. Brain Research 946 2 (2002) 272-282
85. Vezzani A., Rizzi M., Conti M., and Samanin R. Modulatory role of neuropeptides in seizures induced in rats by stimulation of glutamate receptors. The Journal of Nutrition 130 4 S Suppl (2000) 1046S-1048S
86. Vezzani A., Sperk G., and Colmers W.F. Neuropeptide Y: emerging evidence for a functional role in seizure modulation. Trends in Neurosciences 22 1 (1999) 25-30
87. Wilson W.R., Bosy T.Z., and Ruth J.A. NMDA agonists and antagonists alter the hypnotic response to ethanol in LS and SS mice. Alcohol 7 5 (1990) 389-395
88. Wierońska J.M., Smiałowska M., Brański P., Gasparini F., Kłodzińska A., Szewczyk B., Pałucha A., Chojnacka-Wójcik E., and Pilc A. In the amygdala anxiolytic action of mGlu5 receptors antagonist MPEP involves neuropeptide Y but not GABAA signaling. Neuropsychopharmacology 29 3 (2004) 514-521
89. Woldbye D.P.D., Ulrichsen J., Haugbol S., and Bolwig T.G. Ethanol withdrawal in rats is attenuated by intracerebroventricular administration of neuropeptide Y. Alcohol and Alcoholism 37 4 (2002) 318-321
90. Wong S.M.E., Tauck D.L., Fong E.G., and Kendig J.J. Glutamate receptor-mediated hyperexcitability after ethanol exposure in isolated neonatal rat spinal cord. The Journal of Pharmacology and Experimental Therapeutics 285 1 (1998) 201-207
91. Yacoubi M.E.L., Ledent C., Parmentier M., Daoust M., Costentin J., and Vaugeois J.M. Absence of the adenosine A2A receptor or its chronic blockade decrease ethanol withdrawal-induced seizures in mice. Neuropharmacology 40 3 (2001) 424-432
92. Yaka R., Phamluong K., and Ron D. Scaffolding of fyn kinase to the NMDA receptor determines brain region sensitivity to ethanol. The Journal of Neuroscience 23 9 (2003) 3623-3632
93. Yamane F., Tohyama Y., and Diksic M. Continuous ethanol administration influences rat brain 5-hyroxytrytamine synthesis non-uniformly: alpha-[14C]methyl-l-trytophan autoradiographic measurements. Alcohol and Alcoholism 38 2 (2003) 115-120
94. Yoshimoto K., Ueda S., Nishi M., Yang Y., Matsushita H., Takeuchi Y., Kato B., Kawai Y., Noritake K., Kaneda S., Sorimachi Y., and Yasuhara M. Changes in dopamine transporter and c-Fos expression in the nucleus accumbens of alcohol-tolerant rats. Alcoholism: Clinical and Experimental Research 24 3 (2000) 361-365
95. Zafar H., Shelat S.G., Redei E., and Tejani-Butt S. Fetal alcohol exposure alters serotonin transporter sites in rat brain. Brain Research 856 1-2 (2000) 184-192
96. Zapata A., Gonzales R.A., and Shippenberg T.S. Repeated ethanol intoxication induces behavioral sensitization in the absence of a sensitized accumbens dopamine response in C57BL/6 J and DBA/2 J mice. Neuropsychopharmacology 31 2 (2006) 396-405
97. Zhang H., and Pandey S.C. Effects of PKA modulation on the expression of neuropeptide Y in rat amygdaloid structures during ethanol withdrawal. Peptides 24 9 (2003) 1397-1402
98. Zhou F.C., Pu C.F., Murphy J., Lumeng L., and Li T.K. Serotonergic neurons in the alcohol preferring rats. Alcohol 11 5 (1994) 397-403